Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.
Menu

Fennec Pharmaceuticals Inc (FENC)

Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update GlobeNewswire - Tue Aug 11, 6:01AM CDT

~ 2026 Second Quarter Net Product Sales of $17.1 Million, Up 78% Year over Year ~ ~ 2026 Second Quarter Non-GAAP Adjusted EBITDA of $2.8 Million ~ ~...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update GlobeNewswire - Tue Aug 11, 6:01AM CDT

~ 2026 Second Quarter Net Product Sales of $17.1 Million, Up 78% Year over Year ~ ~ 2026 Second Quarter Non-GAAP Adjusted EBITDA of $2.8 Million ~ ~ Record PEDMARK ® Demand Carried...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026 GlobeNewswire - Wed Aug 5, 6:01AM CDT

RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026 GlobeNewswire - Wed Aug 5, 6:01AM CDT

RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire - Mon Jun 22, 5:00AM CDT

RESEARCH TRIANGLE PARK, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire - Mon Jun 22, 5:00AM CDT

RESEARCH TRIANGLE PARK, N.C., June 22, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire - Mon Jun 15, 5:00AM CDT

RESEARCH TRIANGLE PARK, N.C., June 15, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire - Mon Jun 15, 5:00AM CDT

RESEARCH TRIANGLE PARK, N.C., June 15, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Announces Results of Annual Meeting GlobeNewswire - Wed Jun 10, 3:30PM CDT

RESEARCH TRIANGLE PARK, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)
Fennec Announces Results of Annual Meeting GlobeNewswire - Wed Jun 10, 3:30PM CDT

RESEARCH TRIANGLE PARK, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that...

FRX.TO : 17.00 (+9.75%)
FENC : 12.07 (+0.33%)

Barchart Exclusives

Plains All American Stock Is a Top Pick for Growth and Income Barchart - 9 minutes ago
Plains All American Pipeline (PAA) demonstrates strong technical momentum, with shares up more than 45% over the past year. The stock is trading at a new 5-year high. PAA boasts a 6.54% dividend yield, which adds to its appeal. PAA’s crude oil and NGL segments are positioned for volume-driven growth,... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.